News Focus
News Focus
Replies to #72211 on Biotech Values
icon url

jbog

01/26/09 11:34 AM

#72212 RE: DewDiligence #72211

Dew,

Do you recall any of the history or potential of the Dimebon program.

If I recall pfe paid medivation around $200 mil last year. Medivation is only up a couple of pennies today.
icon url

masterlongevity

01/26/09 11:52 PM

#72255 RE: DewDiligence #72211

Bapineuzimab..

i agree. Would not be surprised if they booted it back to Elan...
i think elan is in real trouble. tysabri is going to have some new stiff competition in 1 yr and bapineuzimab is still 3+ yrs from market, assuming it works.